189 related articles for article (PubMed ID: 26458812)
1. The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South Africa.
Chattopadhyay K; Williamson AL; Hazra A; Dandara C
BMC Cancer; 2015 Oct; 15():680. PubMed ID: 26458812
[TBL] [Abstract][Full Text] [Related]
2. A Fas gene polymorphism influences herpes simplex virus type 2 infection in South African women.
Chatterjee K; Dandara C; Gyllensten U; van der Merwe L; Galal U; Hoffman M; Williamson AL
J Med Virol; 2010 Dec; 82(12):2082-6. PubMed ID: 20981796
[TBL] [Abstract][Full Text] [Related]
3. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.
Chatterjee K; Williamson AL; Hoffman M; Dandara C
J Med Virol; 2011 Apr; 83(4):630-6. PubMed ID: 21328377
[TBL] [Abstract][Full Text] [Related]
4. Fas and FasL gene polymorphisms are not associated with cervical cancer but differ among Black and Mixed-ancestry South Africans.
Chatterjee K; Engelmark M; Gyllensten U; Dandara C; van der Merwe L; Galal U; Hoffman M; Williamson AL
BMC Res Notes; 2009 Nov; 2():238. PubMed ID: 19941645
[TBL] [Abstract][Full Text] [Related]
5. CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.
Chatterjee K; Dandara C; Hoffman M; Williamson AL
BMC Cancer; 2010 Jun; 10():278. PubMed ID: 20537184
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction.
Lai HC; Lin WY; Lin YW; Chang CC; Yu MH; Chen CC; Chu TY
Gynecol Oncol; 2005 Oct; 99(1):113-8. PubMed ID: 15996722
[TBL] [Abstract][Full Text] [Related]
7. Functional variants in cell death pathway genes and risk of pancreatic cancer.
Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
[TBL] [Abstract][Full Text] [Related]
8. Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma.
Zhu J; Qin C; Wang M; Yan F; Ju X; Meng X; Ding Q; Li P; Yang J; Cao Q; Zhang Z; Yin C
Mol Carcinog; 2010 Sep; 49(9):810-7. PubMed ID: 20572163
[TBL] [Abstract][Full Text] [Related]
9. FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.
Sun T; Zhou Y; Li H; Han X; Shi Y; Wang L; Miao X; Tan W; Zhao D; Zhang X; Guo Y; Lin D
J Exp Med; 2005 Oct; 202(7):967-74. PubMed ID: 16186185
[TBL] [Abstract][Full Text] [Related]
10. Functional polymorphisms in apoptosis pathway genes and survival in patients with gastric cancer.
Gu D; Du M; Tang C; Chu H; Xu Z; Huo X; Gong W; Tang Y; Zhou J; Tong N; Xu Y; Zhang Z; Wang M; Chen J
Environ Mol Mutagen; 2014 Jun; 55(5):421-7. PubMed ID: 24535941
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women.
La Ruche G; You B; Mensah-Ado I; Bergeron C; Montcho C; Ramon R; Touré-Coulibaly K; Welffens-Ekra C; Dabis F; Orth G
Int J Cancer; 1998 May; 76(4):480-6. PubMed ID: 9590121
[TBL] [Abstract][Full Text] [Related]
12. Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.
Han W; Zhou Y; Zhong R; Wu C; Song R; Liu L; Zou L; Qiao Y; Zhai K; Chang J; Huang L; Liu L; Lu X; Lou J; Yu D; Tan W; Zhang J; Wang H; Miao X
PLoS One; 2013; 8(8):e71656. PubMed ID: 23951214
[TBL] [Abstract][Full Text] [Related]
13. Associations between Fas/FasL polymorphisms and susceptibility to cervical cancer: a meta-analysis.
Wang GQ; Bao L; Zhao XX; Zhang J; Nan KJ
Tumour Biol; 2014 May; 35(5):4107-12. PubMed ID: 24375196
[TBL] [Abstract][Full Text] [Related]
14. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
[TBL] [Abstract][Full Text] [Related]
15. Relationship between polymorphisms in the FAS/FASL death receptor system and progression of low-grade precursor lesions infected with high-risk human papilloma virus.
Santaclara V; Torres-Moreno D; Bernal-Mañas CM; Isaac MA; Ortiz-Reina S; Conesa-Zamora P
Hum Immunol; 2021 Sep; 82(9):621-624. PubMed ID: 34127318
[TBL] [Abstract][Full Text] [Related]
16. Functional polymorphisms in FAS, FASL and CASP8 genes and risk of childhood acute lymphoblastic leukemia: a case-control study.
Tong N; Zhang L; Sheng X; Wang M; Zhang Z; Fang Y; Xue Y; Li J; Zhang Z
Leuk Lymphoma; 2012 Jul; 53(7):1360-6. PubMed ID: 22211869
[TBL] [Abstract][Full Text] [Related]
17. Analysis of cervical lesions for presence of HSV-2 and HPV-16 and HPV-18 in Iranian patients by PCR.
Ahmadi M; Rasi H; Mostafazadeh M; Hajazimian S; Maroufi NF; Nahaei MR; Rahaee S; Isazadeh A
Horm Mol Biol Clin Investig; 2017 Jun; 31(3):. PubMed ID: 28609291
[TBL] [Abstract][Full Text] [Related]
18. The allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women.
Govan VA; Constant D; Hoffman M; Williamson AL
BMC Cancer; 2006 Jan; 6():24. PubMed ID: 16438713
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer.
Smith JS; Herrero R; Bosetti C; Muñoz N; Bosch FX; Eluf-Neto J; Castellsagué X; Meijer CJ; Van den Brule AJ; Franceschi S; Ashley R;
J Natl Cancer Inst; 2002 Nov; 94(21):1604-13. PubMed ID: 12419786
[TBL] [Abstract][Full Text] [Related]
20. P53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women.
Pegoraro RJ; Rom L; Lanning PA; Moodley M; Naiker S; Moodley J
Int J Gynecol Cancer; 2002; 12(4):383-8. PubMed ID: 12144687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]